Tag: Nash treatment

According to the drug manufacturer, Rezdiffra is typically a long-term treatment intended for adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced fibrosis. The answer to **how long do you have to take Rezdiffra** is not a fixed timeline but is a personalized decision made in consultation with a liver specialist based on individual response.

Following its FDA accelerated approval in March 2024, Rezdiffra™ (resmetirom) became the first and only medication specifically approved for treating noncirrhotic nonalcoholic steatohepatitis (NASH). As a specialized treatment, Rezdiffra™ is not available at standard retail pharmacies, and obtaining it requires a specific process involving a prescription and a network of specialty pharmacies.